Product Code: BMIRE00029626
The South & Central America direct-to-consumer genetic testing market was valued at US$ 89.64 million in 2022 and is expected to reach US$ 349.85 million by 2030; it is estimated to grow at a CAGR of 18.6% from 2022 to 2030.
Growing Adoption of Single Nucleotide Polymorphism (SNP) Chips Fuels the South & Central America Direct-to-Consumer Genetic Testing Market
There has been a steady paradigm shift from traditional medicine to personalized medicine with increasing scientific knowledge in recent years. This shift is due to advances in genetic engineering, single nucleotide polymorphism (SNP) genotyping, and the high adoption of microarrays and biochip technologies. The introduction of genetic microarray analysis platforms with hundreds of thousands of SNPs will encourage the implementation of advanced algorithms to test for more secluded genealogical relationships more openly between individuals. In addition, the demand for detecting malignant tumors has also increased. In the pediatric field, the short turnaround time without the need to hybridize SNP variations to massive deletions has led to enormous demand. As a result, the market is expected to grow as more genetic abnormalities are detected and treated.
SNP chips with high efficiency and accuracy are witnessing an increase in demand due to the constant need for technologically advanced and more sophisticated DTC genetic testing. A high preference for SNP chips can be attributed to their ability to measure dosage changes and DNA polymorphism, along with various applications such as the SNP microarray analysis that are vital for cancer research. Furthermore, an increasing need to minimize errors in DTC genetic testing is expected to drive the adoption of SNP technology, thereby providing an opportunity for the market growth.
South & Central America Direct-to-Consumer Genetic Testing Market Overview
The South & Central America direct-to-consumer genetic testing market is segmented into Brazil, Argentina, and the Rest of South & Central America. The market in this region is driven by factors such as the burgeoning incidences of genetic disorders, the growing geriatric population, developments in healthcare systems, and rising awareness about genetic testing. The rising prevalence of the genetic disease, along with chronic illness, is the primary factor driving the growth of Brazil's DTC genetic testing market. For instance, genetic diseases and congenital abnormalities together represent the second most common cause of mortality among infants in Brazil. The growing demand for personalized medicines, introduction of novel technologies in disease diagnosis, and focus of industry players on developing new diagnostic techniques to provide faster results with high accuracy are expected to be other noteworthy factors to favor the growth of the direct-to-consumer genetic testing market in Brazil. The field of medical genetics has expanded in Brazil as scientists assure to track down genetic traits that will help to treat modern disease epidemics, such as obesity and diabetes. Moreover, the number of private genetic testing companies, particularly offering paternity testing solutions, is on the rise in Brazil. In 2019, GENOMIKA, one of the leading genetic testing laboratories in Brazil, signed an agreement with Veritas to incorporate the latter's Whole Genome and Exome Sequencing services associated with preventive medicine and clinical genetics into its portfolio.
South & Central America Direct-to-Consumer Genetic Testing Market Revenue and Forecast to 2030 (US$ Million)
South & Central America Direct-to-Consumer Genetic Testing Market Segmentation
The South & Central America direct-to-consumer genetic testing market is segmented into test type, technology, distribution channel, and country.
Based on test type, the South & Central America direct-to-consumer genetic testing market is segmented into ancestry testing, predictive testing, nutrigenomics testing, carrier testing, and others. The ancestry testing market segment held the largest share in 2022.
In terms of technology, the South & Central America direct-to-consumer genetic testing market is categorized into whole genome sequencing, single nucleotide polymorphism chips, targeted analysis, and others. The single nucleotide polymorphism chips segment held the largest share in 2022.
Based on distribution channel, the South & Central America direct-to-consumer genetic testing market is bifurcated into online , and offline. The online segment held a larger share in 2022.
Based on country, the South & Central America direct-to-consumer genetic testing market is segmented the Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America direct-to-consumer genetic testing market in 2022.
Ancestry Genomics Inc, Living DNA Ltd, 23andMe Inc, and Genetic Technologies Ltd are some of the leading companies operating in the South & Central America direct-to-consumer genetic testing market.
Table Of Contents
Table of Content
1. Introduction
- 1.1 The Insight Partners Research Report Guidance
- 1.2 Market Segmentation
2. Executive Summary
- 2.1 Key Insights
3. Research Methodology
- 3.1 Coverage
- 3.2 Secondary Research
- 3.3 Primary Research
4. South & Central America Direct-to-Consumer Genetic Testing Market Landscape
- 4.1 Overview
5. South & Central America Direct-to-Consumer Genetic Testing Market - Key Industry Dynamics
- 5.1 Market Drivers
- 5.1.1 Growing Incidence of Genetic Disorders
- 5.1.2 Increasing Awareness About Potential Benefits of Genetic Testing
- 5.2 Market Restraints
- 5.2.1 High Cost and Privacy Concerns Associated With Direct-to-Consumer Genetic Testing
- 5.3 Market Opportunities
- 5.3.1 Growing Adoption of Single Nucleotide Polymorphism (SNP) Chips
- 5.4 Future Trends
- 5.4.1 Growing Interest in Pharmacogenetics and Increasing Adoption of Telehealth
- 5.5 Impact Analysis
6. Direct-to-Consumer Genetic Testing Market - South & Central America Market Analysis
- 6.1 Overview
- 6.2 South & Central America Direct-to-Consumer Genetic Testing Market Revenue (US$ Mn), 2022 - 2030
7. South & Central America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 - by Test Type
- 7.1 Overview
- 7.2 South & Central America Direct-to-Consumer Genetic Testing Market Revenue Share, by Test Type 2022 & 2030 (%)
- 7.3 Ancestry Testing
- 7.3.1 Overview
- 7.3.2 Ancestry Testing: South & Central America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
- 7.4 Nutrigenomics Testing
- 7.4.1 Overview
- 7.4.2 Nutrigenomics Testing: South & Central America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
- 7.5 Predictive Testing
- 7.5.1 Overview
- 7.5.2 Predictive Testing: South & Central America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
- 7.6 Carrier Testing
- 7.6.1 Overview
- 7.6.2 Carrier Testing: South & Central America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
- 7.7 Others
- 7.7.1 Overview
- 7.7.2 Others: South & Central America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
8. South & Central America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 - by Technology
- 8.1 Overview
- 8.2 South & Central America Direct-to-Consumer Genetic Testing Market Revenue Share, by Technology 2022 & 2030 (%)
- 8.3 Whole Genome Sequencing
- 8.3.1 Overview
- 8.3.2 Whole Genome Sequencing: South & Central America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
- 8.4 Single Nucleotide Polymorphism Chips
- 8.4.1 Overview
- 8.4.2 Single Nucleotide Polymorphism Chips: South & Central America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
- 8.5 Targeted Analysis
- 8.5.1 Overview
- 8.5.2 Targeted Analysis: South & Central America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
- 8.6 Others
- 8.6.1 Overview
- 8.6.2 Others: South & Central America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
9. South & Central America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 - by Distribution Channel
- 9.1 Overview
- 9.2 South & Central America Direct-to-Consumer Genetic Testing Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
- 9.3 Online Platform
- 9.3.1 Overview
- 9.3.2 Online Platform: South & Central America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
- 9.4 Offline Platform
- 9.4.1 Overview
- 9.4.2 Offline Platform: South & Central America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
10. South & Central America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 - Country Analysis
- 10.1 South & Central America Direct-to-Consumer Genetic Testing Market, By Key Country - Revenue (2022) (US$ Million)
- 10.1.1 South & Central America Direct-to-Consumer Genetic Testing Market Share by Country - 2022 & 2030, (%)
- 10.1.1.1 Brazil: South & Central America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (USD Million)
- 10.1.1.2 Brazil: South & Central America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
- 10.1.1.2.1 Brazil: South & Central America Direct-to-Consumer Genetic Testing Market, by Test Type, 2020-2030 (US$ Million)
- 10.1.1.2.2 Brazil: South & Central America Direct-to-Consumer Genetic Testing Market, By Technology, 2020-2030 (US$ Million)
- 10.1.1.2.3 Brazil: South & Central America Direct-to-Consumer Genetic Testing Market, By Distribution Channel, 2020-2030 (US$ Million)
- 10.1.1.3 Argentina: South & Central America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (USD Million)
- 10.1.1.4 Argentina: South & Central America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
- 10.1.1.4.1 Argentina: South & Central America Direct-to-Consumer Genetic Testing Market, by Test Type, 2020-2030 (US$ Million)
- 10.1.1.4.2 Argentina: South & Central America Direct-to-Consumer Genetic Testing Market, By Technology, 2020-2030 (US$ Million)
- 10.1.1.4.3 Argentina: South & Central America Direct-to-Consumer Genetic Testing Market, By Distribution Channel, 2020-2030 (US$ Million)
- 10.1.1.5 Rest of South & Central America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (USD Million)
- 10.1.1.6 Rest of South & Central America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
- 10.1.1.6.1 Rest of South & Central America Direct-to-Consumer Genetic Testing Market, by Test Type, 2020-2030 (US$ Million)
- 10.1.1.6.2 Rest of South & Central America Direct-to-Consumer Genetic Testing Market, By Technology, 2020-2030 (US$ Million)
- 10.1.1.6.3 Rest of South & Central America Direct-to-Consumer Genetic Testing Market, By Distribution Channel, 2020-2030 (US$ Million)
- 10.1.1 South & Central America Direct-to-Consumer Genetic Testing Market Share by Country - 2022 & 2030, (%)
11. South & Central America Direct-to-Consumer Genetic Testing Market-Industry Landscape
- 11.1 Overview
- 11.2 Organic Developments
- 11.2.1 Overview
- 11.3 Inorganic Developments
- 11.3.1 Overview
12. Company Profiles
- 12.1 Ancestry Genomics Inc
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
- 12.2 Living DNA Ltd
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
- 12.3 23andMe Inc
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
- 12.4 Genetic Technologies Ltd
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
13. Appendix
- 13.1 About Us
- 13.2 Glossary of Terms
